Lifestyle

Samyang Corporation Exempt from 'Starch Price-Fixing Fine'... Daesang Must Pay 234.1 Billion Won

Samyang Corporation Granted Full Exemption Under the Leniency Program Daesang Receives Fair Trade Commission's Decision on the Same Day “We will respond to legal proceedings after receiving the final resolution”

kim mi-kyung
2026-08-31 18:14:38
[Edaily Reporter kim mi-kyung ] Samyang Corporation has been fully exempted from the 210.3 billion won in fines related to the starch price-fixing cartel. In contrast, Daesang received a notice from the Fair Trade Commission requiring it to pay a fine of 234.1 billion won.

Samyang Corporation(145990)The company announced on the 31st that it had received a resolution stating it was exempt from both corrective measures and the order to pay the fine, following a decision by the Fair Trade Commission’s plenary session.

Starch-based products, such as oligosaccharides, are displayed at a large supermarket in Seoul. (Photo = Newsis)

Initially, on the 7th of last month, Samyang Corporation was assessed a fine of 201.3 billion won in connection with sanctions for price-fixing among starch and starch sugar manufacturers. However, the company had yet to complete the formal procedure of receiving the final resolution. The amount of the fine Samyang Corporation was exempted from is equivalent to 11.78% of its equity as of the end of last year. It is reported that the exemption was granted under the leniency program (self-reporting).

#Daesang announced in a disclosure on the same day that it had received the Fair Trade Commission’s resolution. Daesang must pay a fine of 234.1 billion won by October 29. This amount represents 21.34% of its equity as of the end of last year.

Regarding future measures, Daesang stated, “We plan to respond in accordance with the law and procedures after receiving the FTC’s final resolution.”

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02